» Articles » PMID: 31202261

Impaired Neurodevelopmental Pathways in Autism Spectrum Disorder: a Review of Signaling Mechanisms and Crosstalk

Overview
Publisher Biomed Central
Specialties Neurology
Psychiatry
Date 2019 Jun 17
PMID 31202261
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The development of an autistic brain is a highly complex process as evident from the involvement of various genetic and non-genetic factors in the etiology of the autism spectrum disorder (ASD). Despite being a multifactorial neurodevelopmental disorder, autistic patients display a few key characteristics, such as the impaired social interactions and elevated repetitive behaviors, suggesting the perturbation of specific neuronal circuits resulted from abnormal signaling pathways during brain development in ASD. A comprehensive review for autistic signaling mechanisms and interactions may provide a better understanding of ASD etiology and treatment.

Main Body: Recent studies on genetic models and ASD patients with several different mutated genes revealed the dysregulation of several key signaling pathways, such as WNT, BMP, SHH, and retinoic acid (RA) signaling. Although no direct evidence of dysfunctional FGF or TGF-β signaling in ASD has been reported so far, a few examples of indirect evidence can be found. This review article summarizes how various genetic and non-genetic factors which have been reported contributing to ASD interact with WNT, BMP/TGF-β, SHH, FGF, and RA signaling pathways. The autism-associated gene ubiquitin-protein ligase E3A (UBE3A) has been reported to influence WNT, BMP, and RA signaling pathways, suggesting crosstalk between various signaling pathways during autistic brain development. Finally, the article comments on what further studies could be performed to gain deeper insights into the understanding of perturbed signaling pathways in the etiology of ASD.

Conclusion: The understanding of mechanisms behind various signaling pathways in the etiology of ASD may help to facilitate the identification of potential therapeutic targets and design of new treatment methods.

Citing Articles

Gangliosides and Cholesterol: Dual Regulators of Neuronal Membrane Framework in Autism Spectrum Disorder.

Puljko B, Stracak M, Kalanj-Bognar S, Todoric Laidlaw I, Mlinac-Jerkovic K Int J Mol Sci. 2025; 26(3).

PMID: 39941090 PMC: 11818915. DOI: 10.3390/ijms26031322.


Phospho-seq: integrated, multi-modal profiling of intracellular protein dynamics in single cells.

Blair J, Hartman A, Zenk F, Wahle P, Brancati G, Dalgarno C Nat Commun. 2025; 16(1):1346.

PMID: 39905064 PMC: 11794950. DOI: 10.1038/s41467-025-56590-7.


Modelling human brain development and disease with organoids.

Birtele M, Lancaster M, Quadrato G Nat Rev Mol Cell Biol. 2024; .

PMID: 39668188 DOI: 10.1038/s41580-024-00804-1.


Indian Hedgehog (IHh) Protein and COX-2 as Biomarkers to Define the Mechanism of Epilepsy and Gastrointestinal Problems as Comorbid Medical Illnesses in Autism Spectrum Disorder: Combining ROC Curves to Improve Diagnostic Values.

El-Ansary A, Alhakbany M, Alfawaz H, Al-Ayadhi L J Clin Med. 2024; 13(22).

PMID: 39597837 PMC: 11595056. DOI: 10.3390/jcm13226695.


Wnt/β-catenin Signaling in Central Nervous System Regeneration.

Nazli D, Bora U, Ozhan G Adv Exp Med Biol. 2024; 1474():13-33.

PMID: 39511125 DOI: 10.1007/5584_2024_830.


References
1.
Wechsler-Reya R, Scott M . Control of neuronal precursor proliferation in the cerebellum by Sonic Hedgehog. Neuron. 1999; 22(1):103-14. DOI: 10.1016/s0896-6273(00)80682-0. View

2.
Hart M, Concordet J, Lassot I, Albert I, del los Santos R, Durand H . The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell. Curr Biol. 1999; 9(4):207-10. DOI: 10.1016/s0960-9822(99)80091-8. View

3.
Liu P, Wakamiya M, Shea M, Albrecht U, Behringer R, Bradley A . Requirement for Wnt3 in vertebrate axis formation. Nat Genet. 1999; 22(4):361-5. DOI: 10.1038/11932. View

4.
Burden S . Wnts as retrograde signals for axon and growth cone differentiation. Cell. 2000; 100(5):495-7. DOI: 10.1016/s0092-8674(00)80685-6. View

5.
Moore S, Turnpenny P, Quinn A, Glover S, LLOYD D, Montgomery T . A clinical study of 57 children with fetal anticonvulsant syndromes. J Med Genet. 2000; 37(7):489-97. PMC: 1734633. DOI: 10.1136/jmg.37.7.489. View